Gossamer Bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Gossamer Bio generated cash of -$159,158,000, which is more than the previous year. Cash used in financing activities reached the amount of $190,154,000 last year. Net change in cash is therefore -$79,864,000.
Cash Flow
| 2016 | 20K | 0 | 40K |
|---|---|---|---|
| 2017 | -5.74M | 0 | 6M |
| 2018 | -51.04M | -144.71M | 300.85M |
| 2019 | -144.83M | -147.14M | 321.57M |
| 2020 | -176.36M | 215.34M | 312.54M |
| 2021 | -188.89M | -117.42M | 3.32M |
| 2022 | -187.03M | -1.03M | 117.09M |
| 2023 | -159.15M | -110.97M | 190.15M |
GOSS Cash Flow Statement (2016 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 111.97M | 183.46M | 486.62M | 135.08M | 105.41M | 315K | 60K | 60K |
Operating activities | ||||||||
Net income | -179.81M | -229.37M | -234.00M | -243.36M | -180.30M | -146.96M | -6.77M | -83K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 4.38M | 4.42M | 5.16M | 4.26M | 3.08M | 297K | 0 | 0 |
Stock-based compensation expense | 28.51M | 42.55M | 32.00M | 38.74M | 20.81M | 0 | 32K | 0 |
| Deferred income tax benefit | 28.51M | 42.55M | 32.00M | 38.74M | 20.81M | 0 | 32K | 0 |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 3.99M | -1.81M | -4.42M | 6.98M | -1.39M | 2.08M | 57K | 103K |
Cash generated by operating activities | -159.15M | -187.03M | -188.89M | -176.36M | -144.83M | -51.04M | -5.74M | 20K |
Investing activities | ||||||||
Purchases Of Investments | -441.67M | -238.06M | -152.03M | -108.96M | -499.07M | -123.5M | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -475K | -1.62M | -24.88M | -6.56M | -21.21M | 0 | 0 |
Acquisitions Net | 0 | -65K | 75K | 23.38M | 3.6M | -17.72M | 0 | 0 |
Cash generated by investing activities | -110.97M | -1.03M | -117.42M | 215.34M | -147.14M | -144.71M | 0 | 0 |
Financing activities | ||||||||
Common Stock Issued | 201.32M | 119.94M | 3.32M | 117.11M | 291.31M | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -11.61M | -5.80M | 0 | -193.59M | 28.22M | -40K | 6M | 0 |
Cash used in financing activities | 190.15M | 117.09M | 3.32M | 312.54M | 321.57M | 300.85M | 6M | 40K |
Net Change In Cash | -79.86M | -71.49M | -303.15M | 351.53M | 29.67M | 105.10M | 255K | 0 |
Cash at end of period | 32.10M | 111.97M | 183.46M | 486.62M | 135.08M | 105.41M | 315K | 60K |
| Data source | Data source | Data source | Data source | Data source | Data source |